

AID-ICU Trial
Mar 13, 2024
Explore the AID-ICU trial investigating the use of Haloperidol for delirium in the ICU, with insights from experts discussing impact, findings, and limitations. Reflect on outcome assessment in clinical trials during a pandemic, patient experiences, and the effectiveness of Haloperidol in treating uncontrollable delirium.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Analyzing Haloperidol Treatment in ICU Patients with Delirium
02:27 • 18min
Analyzing the Impact of Haloperidol Trials on Delirium Treatment in the ICU
20:50 • 6min
Reflections on Outcome Assessment in Clinical Trials and Pandemic Considerations
27:16 • 3min
Patient Experience and Importance of Delirium Recognition in ICU Care
30:17 • 3min
Exploring the Use of Haloperidol in Uncontrollable Delirium Treatment
33:34 • 5min